Alignment Healthcare, Inc. (ALHC)
NASDAQ: ALHC · IEX Real-Time Price · USD
7.88
-0.09 (-1.13%)
At close: Jul 2, 2024, 4:00 PM
7.73
-0.15 (-1.90%)
After-hours: Jul 2, 2024, 4:36 PM EDT
Alignment Healthcare Stock Forecast
Stock Price Forecast
The 10 analysts with 12-month price forecasts for ALHC stock have an average target of 8.83, with a low estimate of 4.50 and a high estimate of 12. The average target predicts an increase of 12.06% from the current stock price of 7.88.
Analyst Consensus: Buy
* Price targets were last updated on May 30, 2024.
Analyst Ratings
The average analyst rating for ALHC stock from 10 stock analysts is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Jan '24 | Feb '24 | Mar '24 | Apr '24 | May '24 | Jun '24 |
|---|---|---|---|---|---|---|
| Strong Buy | 3 | 3 | 3 | 2 | 2 | 2 |
| Buy | 3 | 3 | 1 | 1 | 3 | 3 |
| Hold | 4 | 4 | 5 | 5 | 4 | 4 |
| Sell | 0 | 0 | 1 | 1 | 1 | 1 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 10 | 10 | 10 | 9 | 10 | 10 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Baird | Baird | Buy Initiates $10 | Buy | Initiates | $10 | +26.90% | May 30, 2024 |
| Piper Sandler | Piper Sandler | Hold → Buy Upgrades $6 → $8 | Hold → Buy | Upgrades | $6 → $8 | +1.52% | May 8, 2024 |
| Stephens & Co. | Stephens & Co. | Hold Maintains $6 → $7 | Hold | Maintains | $6 → $7 | -11.17% | May 3, 2024 |
| Stifel | Stifel | Strong Buy Maintains $11 → $9 | Strong Buy | Maintains | $11 → $9 | +14.21% | Apr 23, 2024 |
| Piper Sandler | Piper Sandler | Buy → Hold Downgrades $12 → $6 | Buy → Hold | Downgrades | $12 → $6 | -23.86% | Mar 6, 2024 |
Financial Forecast
Revenue This Year
2.11B
from 1.82B
Increased by 15.76%
Revenue Next Year
2.57B
from 2.11B
Increased by 21.89%
EPS This Year
-0.21
from -0.79
EPS Next Year
-0.69
from -0.21
Revenue Forecast
| Revenue | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | 2.7B | 3.5B | 3.3B | 4.6B | 5.6B |
| Avg | 2.6B | 3.2B | 3.2B | 4.5B | 5.4B |
| Low | 2.5B | 2.9B | 3.1B | 4.3B | 5.2B |
Revenue Growth
| Revenue Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | 47.0% | 37.4% | 3.2% | 45.7% | 23.7% |
| Avg | 41.1% | 23.1% | 0.3% | 41.6% | 20.2% |
| Low | 34.6% | 14.1% | -3.7% | 36.0% | 15.5% |
EPS Forecast
| EPS | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | -0.62 | -0.30 | -0.25 | 0.14 | 0.45 |
| Avg | -0.69 | -0.53 | -0.24 | 0.13 | 0.44 |
| Low | -0.73 | -0.70 | -0.24 | 0.13 | 0.42 |
EPS Growth
| EPS Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | - | - | - | - | 240.5% |
| Avg | - | - | - | - | 230.8% |
| Low | - | - | - | - | 217.8% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.